Company: OTSA
Filing Date: 2025-03-26
Form Type: DRS/A
Source: 0001013762-25-002776
Chunk: 130

Company: OTSAW Ltd
Filing Date: 2025-03-26
Form: DRS/A
Chunk 130
---
 a decrease in deferred consideration payable to Swisslog Healthcare Holding AG for the acquisition of Swisslog assets. Net cash used in operating activities for the year ended April 30, 2023 was approximately US$4.6 million, the difference between our net loss of approximately US$6.7 million and the net cash used in operating activities was primarily attributable to (i) depreciation and amortization expense of US$1.5 million on property, plant and equipment, intangible assets based on our accounting policies; (ii) finance cost of US$0.7 million in relation to loans from related parties; (iii) impairment and write off of assets of approximately US$1.0 million; (iv) an increase of approximately US$0.2 million in trade and other payables, which aligned with the expansion in sales activities, leading to an increase in purchase of components to support operations; partially offset by (v) an increase in inventories of US$0.3 million, primarily attributable to predictable sales growth expectations; and (vi) an increase of approximately US$0.5 million in trade and other receivables due to intensified sales activities with our customers near the year end. Investing activities Net cash used in investing activities for the years ended April 30, 2024 and 2023 was approximately US$0.5 million and US$0.3 million, respectively, which was entirely spent on the purchase of property, plant and equipment and investment in intangible assets. Financing activities Net cash generated from financing activities for the year ended April 30, 2024 was approximately US$2.8 million. This was primarily due to (i) proceeds from related party loans of approximately US$3.8 million; (ii) repayment of related party loans of approximately US$0.7 million; and (iii) repayment of lease liabilities of approximately US$0.3 million. Net cash generated from financing activities for the year ended April 30, 2023 was approximately US$4.1 million. This was primarily due to (i) proceeds from related party loans of approximately US$8.2 million; (ii) repurchase of ordinary shares of approximately US$0.8 million; (iii) repayment of other financial liability of approximately US$3.1 million; and (iv) repayment of lease liabilities of approximately US$0.3 million.

82 Quantitative and Qualitative Disclosures about Market Risks Foreign currency translation and foreign currency risks Our reporting currency is United States